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Introduction 
Total Knee Arthroplasty (TKA) is currently regarded as 
the most effective treatment for osteoarthritis. There is 
an increasing number of knees being replaced every 
year not only in the United States but also worldwide.1 
Because of the economic burden of TKAs, there has been 
a push towards finding cost-effective strategies to 
reduce the financial burden on both hospitals and 
patients alike.2 In the US alone, total knee replacements 
(TKR) cost insurance providers several billion dollars per 
year. In developing and developed countries alike, there 
has also been an inclination towards the 
implementation of fast track surgical procedures which 
intend to bring about cost effectiveness. Previous 
studies have shown that length of stay (LOS) is an 
important factor contributing to the increasing cost. 
Various patient and surgeon-based predictors have 
been identified that contribute significantly to an 
increased LOS such as age,3-5 body mass index (BMI)(5), 
co-morbids,4,6 gender,6 preoperative haemoglobin (Hb) 
level and the need for postoperative transfusion.3,5 
Although this has been the subject of several studies, 
the results have been contradictory. 
The current study was planned to look at various 
preoperative, intraoperative and postoperative factors 
that significantly contribute to increased LOS in patients 
undergoing TKA. 
Materials and Methods 
The retrospective cohort study was conducted at the 
Aga Khan University Hospital (AKUH), Karachi, and 
comprised record of patients regardless of gender, co-
morbids and age who had undergone a unilateral or 
bilateral TKA between January 2007 and December 
2015. After approval from the institutional ethics review 
committee, records for all TKAs done within the time 
period were accessed. Patients who had undergone a 
revision TKA were excluded and so were those with 
missing data. 
Medical records were reviewed and a proforma was used 
to note down demographic data, including age, gender, 
co-morbids, American Society of Anesthesiologists 
(ASA) grade, and clinical data, including type of surgery, 
total operative time from incision to skin closure, total 
tourniquet time, the need for postoperative transfusion, 
LOS from admission to discharge, postoperative special 
care unit (SCU) stay, preoperative/postoperative Hb and 
haematocrit and postoperative complications. Nadler's 
formula was used to calculate the estimated blood 
volume of a person.7 Intraoperative blood loss was 
calculated using the Gross formula, which has been 
previously used for calculating blood loss in total hip 
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arthroplasties.8 SCUs are in-patient nurse-led units for 
the management of the chronically and critically ill. 
These are distinct from intensive care units (ICUs) and 
are usually managed by a team of nurses and a 
pulmonologist. 
The LOS data was skewed when tested with both 
Kolmogrov-Smirnov and Shapiro-Wilk tests. As such, 
non-parametric tests were used accordingly for data 
analysis. Dichotomous categorised data was analysed 
using Mann-Whitney U test. Data that was categorised 
into 3 or more groups, such as age, ASA grade, total 
operative time, total tourniquet time, and estimated 
blood loss, was analysed using Kruskal Wallis Test. 
Spearman's correlation coefficient was also done to 
assess correlations between significant variables in 
univariate analysis. 
LOS was dichotomised into two categories based on the 
skewed data. A high LOS was defined as greater than or 
equal to 11 days (75th centile). Further comparison was 
carried out between categoriszed variables and 
dichotomised LOS and significant predictors 
contributing to an LOS of more than 11 days were 
identified using Pearson chi-square test. Multivariate 
logistic regression analysis was carried out between 
significant predictors to identify the most important 
predictors that contributed to increased LOS while 
adjusting for confounders. 
Results 
Of the 577 patients, 448(77.6%) were women. Overall, 
311(53.9%) patients were aged 56-70 years. There was a 
weak but positive correlation between BMI and LOS 
(p=0.017). Both preoperative and postoperative Hb 
levels were found to have a significant negative 
correlation with LOS (p=0.003 each). A weak but 
significant correlation was also found between 
increasing ASA grades and LOS (p=0.03) (Table-1). 
Simultaneous bilateral TKA was associated with a 
significantly higher median LOS (and it was also a 
significant predictor of LOS >11 days (p<0.05). There was 
a positive significant correlation between operative time 
and LOS (p<0.001) and increased total operative time 
was significant independent predictor for LOS >11 days 
(p<0.05). Other significant independent predictors 
included postoperative SCU stay, postoperative 
transfusion need, complications during stay and urinary 
tract infection (UTI) (Table-2). 
Multivariate logistic regression done on all the significant 
independent predictors suggested only the type of 
surgery, postoperative SCU stay and the need for 
postoperative transfusion as being significant (Table-3). 
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Table-1: Comparison of Variables using Mann-Whitney1 and Kruskal Wallis2 test. 
 
Variables                                                            Number                 Median LOS             (P - Value) 
                                                                             (n=577)             (days) with IQR                     
 
Age 
0-55                                                                 154(26.7%)               8.0 (7-10)                   0.8462 
56-70                                                               311(53.9%)               8.0 (7-10)                          
71+                                                                  112(19.4%)               8.0 (7-10)                          
Gender 
Male                                                                   129(22.4)                 8.0 (7-10)                   0.3961 
Female                                                            448 (77.6%)               8.0 (7-10)                          
Co-morbid 
Diabetes Mellitus                                         165(28.6%)               9.0 (7-10)                    0.037 
Hypertension                                                337(58.4%)               8.0 (7-10)                    0.915 
COPD/Asthma                                                 32(5.5%)               9.0 (7.25-10)                 0.237 
Hyperthyroidism                                             5(0.9%)                   8.0 (7-12)                    0.977 
Hypothyroidism                                              53(5.5%)                  9.0 (7-11)                    0.158 
Dyslipidaemia                                                 21(3.6%)                        9.0                          0.558 
CKD                                                                     16(2.8%)                  9.0 (8-12)                    0.035 
BMI 
<24.9                                                               76 (13.1%)                 8.0 (7-9)                    0.0212 
25-29.9                                                           179 (31.0%)                8.0 (7-9)                            
30-34.9                                                           199 (34.5%)               8.0 (7-10)                          
>35                                                                 123 (21.3%)               9.0 (8-10)                          
Type of Surgery 
Unilateral                                                       255(44.2%)                7.0 (6-9)                  <0.0011 
Bilateral                                                          321(55.6%)               9.0 (8-10)                          
ASA 
I                                                                            30(5.2%)                8.0 (6.75-9)                 0.0722 
II                                                                        416(72.1%)               8.0 (7-10)                          
III                                                                       130(22.5%)               9.0 (7-11)                          
IV                                                                         1(0.17%)                        8.0                                 
Operative Time (min) 
0-160                                                               217(37.6%)                8.0 (7-9)                  <0.0012 
160-260                                                          223(38.6%)               9.0 (7-10)                          
>260                                                               137(23.7%)               9.0 (8-10)                          
Estimated Blood Loss (ml) 
0-500                                                               192(33.3%)               8.0 (7-10)                   0.2122 
500-800                                                          176(30.5%)                8.0 (7-9)                            
>800                                                               209(36.2%)               9.0 (7-10)                          
Pre-Operative Hb (gm/dl) 
<12                                                                  230(39.9%)               9.0 (7-10)                   0.0091 
>12                                                                  347(60.1%)               8.0 (7-10)                          
Post-Operative Hb(gm/dl) 
<12                                                                  509(88.2%)               8.0 (7-10)                   0.0131 
>12                                                                   68(11.8%)                8.0 (7-10)                          
Post-Operative SCU (days) 
Yes                                                                      25(4.3%)                  9.0 (8-13)                   0.0061 
No                                                                     552(95.7%)               8.0 (7-10)                          
Post-Operative Transfusion Need 
Yes                                                                    105(18.2%)              10.0 (8-12)                <0.0011 
No                                                                     472(81.8%)                8.0 (7-9)                            
Complications During Stay (UTI, SSI, DVT and Cardiac) 
Yes                                                                    89 (15.4%)                9.0 (8-12)                   0.0011 
No                                                                    488 (84.6%)                8.0 (7-9)                            
 
LOS: Length of stay; UTI: Urinary tract infection; SSI: Surgical site infection; DVT: Deep venous 
thrombosis; SCU: Special care unit; Hb: Haemoglobin; BMI: Body mass index; COPD: Chronic Obstructive 
Pulmonary Disease; CKD: Chronic kidney disease; ASA: American Society of Anaesthesiologists.
Discussion 
In our study, the only significant variables contributing to 
an increased LOS after multivariate analysis were the type 
of surgery, postoperative SCU stay and the need for 
postoperative transfusion. Though increasing BMI, higher 
ASA grades, preoprative Hb<12, postoperative Hb<12, 
complications during stay and UTI were found to be 
significantly associated with a higher LOS, the 
significance was lost after multivariate analysis. 
Our findings were similar to previous studies showing 
that bilateral TKA is associated with a longer LOS 
compared to those who underwent a unilateral TKA.9-12 
Bilateral TKA is associated with bilateral soft tissue trauma 
at the knee and results in more pain and therefore a 
longer time to ambulation. However, conflicting evidence 
still remains with multiple studies showing that there is 
no significant difference in LOS between the two 
groups.13-15 It is possible that there is a marked difference 
present between clinical care pathways in various 
countries, which could account for the difference in 
postoperative care and findings. Studies done evaluating 
LOS worldwide have shown that there is marked 
discrepancy between the average LOS worldwide due to 
a difference in clinical care and rehabilitation protocol.16-
18 Moreover, in our part of the world with a predominant 
pay for service and low health insurance rates, there are 
no rehabilitation facilities for these patients. Therefore 
these patients are discharged once they become 
functional and can independently take care of themselves 
with respect to mobility and activities of daily living. 
Previous studies have shown that postoperative blood 
transfusion is associated with increased LOS.5,19,20 It has 
been suggested that identifications of risk factors of 
allogenic transfusion and minimising the use of allogenic 
transfusion will significantly alter LOS. Monsef et al. 
showed that allogenic blood transfusion and the number 
of units transfused had a significant impact on increasing 
LOS. Similar to our findings, the study also showed that 
preoperative Hb levels had a negative correlation with 
LOS.21 Autologous blood transfusion has been suggested 
as an alternative to allogenic blood transfusion in 
anaemic patients.22 
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Table-2: Univariate Comparison using Chi-Square between variables in those staying at 
least 11 days. 
 
Variables                                      Number of with LOS >=11 days (n=100)            (P-Value) 
 
Age (years) 
0-55                                                                             27(17.5%)                                              0.992 
56-70                                                                           54(17.4%)                                                    
71+                                                                             19(17.0%)                                                    
Gender 
Male                                                                            75 (16.7%)                                             0.485 
Female                                                                       25 (19.4%)                                                    
Co-morbid 
Diabetes Mellitus                                                    28(17.0%)                                              0.885 
Hypertension                                                            57(16.9%)                                              0.754 
COPD/Asthma                                                            7(21.9%)                                               0.485 
Hyperthyroidism                                                         1(20%)                                                 0.874 
Hypothyroidism                                                        9(28.1%)                                               0.097 
Dyslipidaemia                                                           3 (14.3%)                                              0.707 
CKD                                                                               5 (31.2%)                                              0.136 
BMI 
<24.9                                                                          12(15.8%)                                              0.570 
25-29.9                                                                       27(15.1%)                                                    
30-34.9                                                                       35(17.6%)                                                    
>35                                                                             26 (21.1%)                                                    
Type of Surgery 
Unilateral                                                                    23(9.0%)                                              0.000* 
Bilateral                                                                      77(24.0%)                                                    
ASA 
I                                                                                        2(6.7%)                                               0.013* 
II                                                                                    64(15.4%)                                                    
III                                                                                   34(26.2%)                                                    
IV                                                                                           0                                                             
Operative Time (min) 
0-160                                                                           24(11.1%)                                            0.007* 
160-260                                                                      45(20.2%)                                                    
>260                                                                           31(22.6%)                                                    
Estimated Blood Loss 
0-500                                                                           32(16.7%)                                              0.520 
500-800                                                                      27(15.3%)                                                    
>800                                                                           41(19.6%)                                                    
Pre-Operative Hb 
<12                                                                             49(21.3%)                                              0.04* 
>12                                                                             51(14.7%)                                                    
Post-Operative Hb 
<12                                                                             94 (18.5%)                                            0.048* 
>12                                                                                6(8.8%)                                                       
Post-Operative SCU 
Yes                                                                                11(44.0%)                                            0.000* 
No                                                                                 89(16.1%)                                                    
Post-Operative Transfusion Need 
Yes                                                                                44(41.9%)                                           <0.001* 
No                                                                                 56(11.9%)                                                    
Complications During Stay 
Yes                                                                                28(31.5%)                                           <0.001* 
No                                                                                 72(14.8%)                                                    
UTI 
Yes                                                                                 6(46.2%)                                              0.005* 
No                                                                                 94(16.7%)                                                    
 
LOS: Length of stay; UTI: Urinary tract infection; SSI: Surgical site infection; DVT: Deep venous 
thrombosis; SCU: Special care unit; Hb: Haemoglobin; BMI: Body mass index; COPD: Chronic Obstructive 
Pulmonary Disease; CKD: Chronic kidney disease; ASA: American Society of Anaesthesiologists.
Table-3: Multivariate Logistic Regression Analysis carried out among significant 
predictor variables. 
 
Variables                                                                Adjusted Odds Ratio [CI - 95%]          P-value 
 
Type of Surgery                                                                2.425 [1.39, 4.20]                         0.002 
Post-Operative Special Care Unit(SCU) stay            2.789 [1.10, 7.05]                         0.030 
Post-Operative Transfusion                                          3.492 [2.04, 5.99]                       <0.001 
 
CI: Confidence interval.
We found postoperative SCU stay to be associated 
with greater LOS. A previous study done in Canada 
showed that a significant percentage of patients who 
spent at least some time in the SCU had LOS more than 
twice as long as those who did not stay in the SCU.23 
Minimising the SCU time by identifying risk factors 
responsible for an increased stay would be beneficial 
in reducing the total LOS overall. Our study did not 
assess any major intraoperative risks and 
postoperative risk factors that contributed to an 
overall increased SCU stay. 
Total operative time was significant univariate predictor 
of increased LOS but after multivariate analysis it did 
not remain significant. The most likely reason would be 
that in both cases, type of surgery played an important 
confounding role. Similarly, even though past 
researches have indicated an increased ASA grade 
associated with higher LOS,24 we found no association 
between higher ASA grades (3/4) with longer LOS. A 
very recent study comparing increasing BMI levels and 
LOS showed that higher BMI had a dose response effect 
on LOS.25 Similarly, Jonas et al. showed that ASA grade, 
BMI and age were significant factors contributing to an 
increased LOS.5 Our study, however, did not show any 
significant association between these factors and 
increased LOS. 
This was a retrospective cohort study, and, as is the case 
with all such studies, there is a possibility of 
uncontrolled confounding factors playing a role. There 
was no detailed patient data on monthly financial 
income, marital status etc. that could have been 
included in the analysis. In addition, no data was 
gathered on the number of days spent in post-
anaesthesia care unit (PACU) or SCU in order to further 
determine whether a specific number of days 
contributed to increased LOS. Also, no data was 
gathered with respect to how much blood was 
transfused and on which postoperative day. Previous 
researches have shown that both of these have a 
significant contribution to increased LOS. Our research is 
based on findings from a single tertiary care hospital in 
Pakistan. Though the hospital is one of the major referral 
centres of the country, the results cannot be generalised 
due to differences in preoperative and postoperative 
care in various regions and health facilities. As such, 
there is a need for a prospective study to identify further 
factors contributing to LOS. 
Conclusion 
Bilateral TKA, postoperative transfusion and 
postoperative SCU stay were found to be associated with 
increased LOS. Identification of risk factors of 
postoperative allogenic transfusion and SCU stay will be 
useful in identifying patients who will stay longer.  
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